Glenmark gets USFDA nod for acne treatment drug – ET HealthWorld

New Delhi: Drug major Glenmark Pharma on Thursday said it has received final approval from the US health regulator for Clindamycin Phosphate Gel, used to treat acne. The approved product is a generic version of Cleocin T Gel, 1 per cent, of Pharmacia & Upjohn.

Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Gel USP, 1 per cent, the company said in a regulatory filing.

Quoting IQVIA sales data for the 12 month period ending December 2020, Glenmark said Cleocin T Gel, 1 per cent, market achieved annual sales of approximately USD 73.8 million.

Glenmark said the current portfolio consists of 169 products authorised for distribution in the US marketplace and 42 abbreviated new drug applications are pending approval with the USFDA.

Shares of Glenmark Pharma were trading 0.63 per cent lower at Rs 504.25 apiece on BSE.

Follow and connect with us on , Facebook, Linkedin

Source link


Nishant Agrawal introduces VSN Groups that is one of the most popular blogs on Online Shopping & Trending Breaking News and updated information. The #1 thing about this blog is that it’s the most popular blog that covers news, fashion, lifestyle, healthcare, education, digital marketing, and so on where you’ll also discover a ton of shopping & get updates and tips on fashion, lifestyle, better living and so on.

Leave a Reply

Your email address will not be published. Required fields are marked *